Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation

被引:99
作者
Vorlova, Sandra
Rocco, Gina [2 ]
Le Fave, Clare V. [2 ]
Jodelka, Francine M. [3 ]
Hess, Ken [2 ]
Hastings, Michelle L. [3 ]
Henke, Erik [4 ]
Cartegni, Luca [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Ctr Expt Therapeut, New York, NY 10065 USA
[2] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA
[3] Rosalind Franklin Univ, Chicago Med Sch, Chicago, IL 60064 USA
[4] Univ Wurzburg, Inst Clin Biochem, D-97080 Wurzburg, Germany
基金
美国国家卫生研究院;
关键词
PRE-MESSENGER-RNA; MAMMALIAN-CELLS; CARCINOMA-CELLS; IN-VIVO; POLYADENYLATION; GROWTH; CANCER; GENE; OLIGONUCLEOTIDES; INHIBITION;
D O I
10.1016/j.molcel.2011.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alternative intronic polyadenylation (IPA) can generate truncated protein isoforms with significantly altered functions. Here, we describe 31 dominant-negative, secreted variant isoforms of receptor tyrosine kinases (RTKs) that are produced by activation of intronic poly(A) sites. We show that blocking U1-snRNP can activate IPA, indicating a larger role for U1-snRNP in RNA surveillance. Moreover, we report the development of an antisense-based method to effectively and specifically activate expression of individual soluble decoy RTKs (sdRTKs) to alter signaling, with potential therapeutic implications. In particular, a quantitative switch from signal transducing full-length vascular endothelial growth factor receptor-2 (VEGFR2/KDR) to a dominant-negative sKDR results in a strong antiangiogenic effect both on directly targeted cells and on naive cells exposed to conditioned media, suggesting a role for this approach in interfering with angiogenic paracrine and autocrine loops.
引用
收藏
页码:927 / 939
页数:13
相关论文
共 35 条
[1]   Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth [J].
Albuquerque, Romulo J. C. ;
Hayashi, Takahiko ;
Cho, Won Gil ;
Kleinman, Mark E. ;
Dridi, Sami ;
Takeda, Atsunobu ;
Baffi, Judit Z. ;
Yamada, Kiyoshi ;
Kaneko, Hiroki ;
Green, Martha G. ;
Chappell, Joe ;
Wilting, Joerg ;
Weich, Herbert A. ;
Yamagami, Satoru ;
Amano, Shiro ;
Mizuki, Nobuhisa ;
Alexander, Jonathan S. ;
Peterson, Martha L. ;
Brekken, Rolf A. ;
Hirashima, Masanori ;
Capoor, Seema ;
Usui, Tomohiko ;
Ambati, Balamurali K. ;
Ambati, Jayakrishna .
NATURE MEDICINE, 2009, 15 (09) :1023-U74
[2]   Anti-tumor activity of splice-switching oligonucleotides [J].
Bauman, John A. ;
Li, Shyh-Dar ;
Yang, Angela ;
Huang, Leaf ;
Kole, Ryszard .
NUCLEIC ACIDS RESEARCH, 2010, 38 (22) :8348-8356
[3]   Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2 [J].
Becker, Juergen ;
Pavlakovic, Helena ;
Ludewig, Fabian ;
Wilting, Fabiola ;
Weich, Herbert A. ;
Albuquerque, Romulo ;
Ambati, Jayakrishna ;
Wilting, Joerg .
CLINICAL CANCER RESEARCH, 2010, 16 (05) :1431-1441
[4]   Tyrosine kinase receptors as attractive targets of cancer therapy [J].
Bennasroune, A ;
Gardin, A ;
Aunis, D ;
Crémel, G ;
Hubert, P .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (01) :23-38
[5]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[6]   Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA [J].
Fortes, P ;
Cuevas, Y ;
Guan, F ;
Liu, P ;
Pentlicky, S ;
Jung, SP ;
Martínez-Chantar, ML ;
Prieto, J ;
Rowe, D ;
Gunderson, SI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8264-8269
[7]   Gene silencing by synthetic U1 Adaptors [J].
Goraczniak, Rafal ;
Behlke, Mark A. ;
Gunderson, Samuel I. .
NATURE BIOTECHNOLOGY, 2009, 27 (03) :257-263
[8]   U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase [J].
Gunderson, SI ;
Polycarpou-Schwarz, M ;
Mattaj, IW .
MOLECULAR CELL, 1998, 1 (02) :255-264
[9]   Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity [J].
He, YL ;
Smith, SK ;
Day, KA ;
Clark, DE ;
Licence, DR ;
Charnock-Jones, DS .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (04) :537-545
[10]   Soluble receptors in human disease [J].
Heaney, ML ;
Golde, DW .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 64 (02) :135-146